Arlington Financial Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$335K Sell
1,372
-7
-0.5% -$1.63K 0.05% 75
2025
Q4
$285K Buy
1,379
+74
+6% +$14.6K 0.04% 86
2025
Q3
$242K Buy
+1,305
New +$224K 0.04% 101
2025
Q2
Sell
-5,342
Closed -$886K 97
2025
Q1
$886K Buy
+5,342
New +$836K 0.16% 61
2023
Q1
Sell
-1,147
Closed -$203K 65
2022
Q4
$203K Sell
1,147
-80
-7% -$13.8K 0.09% 63
2022
Q3
$200K Buy
+1,227
New +$208K 0.1% 51
2022
Q1
Sell
-1,196
Closed -$205K 69
2021
Q4
$205K Sell
1,196
-90
-7% -$14.7K 0.07% 76
2021
Q3
$208K Sell
1,286
-2,772
-68% -$473K 0.08% 59
2021
Q2
$669K Buy
4,058
+50
+1% +$8.28K 0.25% 45
2021
Q1
$659K Sell
4,008
-175
-4% -$28.3K 0.27% 46
2020
Q4
$658K Sell
4,183
-1,435
-26% -$212K 0.28% 46
2020
Q3
$836K Buy
5,618
+1,374
+32% +$203K 0.43% 40
2020
Q2
$597K Sell
4,244
-1,776
-30% -$259K 0.34% 42
2020
Q1
$789K Sell
6,020
-11,999
-67% -$1.7M 0.56% 35
2019
Q4
$2.63M Sell
18,019
-7,153
-28% -$970K 1.46% 23
2019
Q3
$3.26M Sell
25,172
-425
-2% -$56K 1.86% 16
2019
Q2
$3.56M Buy
25,597
+405
+2% +$56.1K 2.04% 16
2019
Q1
$3.52M Buy
25,192
+1,571
+7% +$210K 2% 17
2018
Q4
$3.05M Sell
23,621
-627
-3% -$87.5K 1.3% 25
2018
Q3
$3.52M Sell
24,248
-189
-0.8% -$25.1K 2.11% 17
2018
Q2
$3.24M Buy
24,437
+1,250
+5% +$156K 1.88% 16
2018
Q1
$3.01M Sell
23,187
-3
-0% -$405 1.98% 16
2017
Q4
$3.35M Buy
+23,190
New +$3.23M 1.58% 18

Other funds holding JNJ

Arlington Financial Advisors's JNJ Position: Q1 2026 in Review

Arlington Financial Advisors reduced its Johnson & Johnson (JNJ) stake by 0.51% in Q1 2026, selling an estimated $1.63K and leaving 1,372 shares worth $335K. The position accounts for 0.05% of the portfolio, ranked #75.

Arlington Financial Advisors first reported a position in JNJ in Q4 2017 and has held it in 23 quarters since. The position peaked at $3.56M in Q2 2019. 4,612 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Arlington Financial Advisors held 1,372 shares of Johnson & Johnson worth $335K as of Q1 2026.
  • Arlington Financial Advisors sold 7 Johnson & Johnson shares in Q1 2026, an estimated $1.63K.
  • Johnson & Johnson made up 0.05% of Arlington Financial Advisors's portfolio in Q1 2026, its #75 holding.
  • Arlington Financial Advisors first reported a position in Johnson & Johnson in Q4 2017 and has held it in 23 quarters since.
  • Arlington Financial Advisors's Johnson & Johnson position peaked at $3.56M in Q2 2019.
  • 4,612 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Arlington Financial Advisors's 13F filing for Q1 2026, filed 15 Apr 2026.